Compounding Pharmacies: "Novo Nordisk A/S, the maker of Ozempic, said it doesn’t supply ingredients to compounders and issued a warning earlier this year about compounded semaglutide. The Danish pharmaceutical giant holds the patent on semaglutide, making it difficult for others to precisely replicate the drug, and it is suing several companies for patent infringement. Some compounders are mixing the drug with supplements, according to providers prescribing them to patients. Already, several recalls have been reported to the FDA".

 

1. If Ozempic Is in Short Supply, How Are People Getting It for …

   https://www.wsj.com/articles/ozempic-weight-loss-drug-supply-11669927944

   WebRecently, she said, her patients have been asking for Ozempic to help them lose weight. …